Joseph Paul Eder, MD

Professor of Medicine (Medical Oncology)

Patient Care

Accepts new patients? Yes
Patient Type: Adult
Referrals: From patients or physicians

Patient Care Organizations

Medical Oncology: Early Drug Development Program | Subset Medical Oncology Faculty

Cancer Center, Yale

Yale Medical Group

Board Certifications

  • Internal Medicine AB of Internal Medicine (1981)

  • Medical Oncology AB of Internal Medicine (1983)

  • Hematology (Internal Medicine) AB of Internal Medicine (1984)

Clinical Trials

Conditions Study Title
Anus, Bladder, Bones and Joints, Brain and Nervous System, Breast - Female, Breast - Male, Cervix Uteri, Colon, Esophagus, Eye and Orbit, Kaposi's sarcoma, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Phase I A Phase 1 Study Evaluating Antitumor Activity of Entinostat and Nivo with or w/o Ipi
Anus, Bladder, Breast - Female, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Phase I, Unknown Sites BP29435 - A Phase IB of RO6895882 (IL-2v) and MPDL3280A (PD-L1) Metastatic Solid Tumors
Anus, Bladder, Breast - Female, Colon, Esophagus, Kidney, Larynx, Leukemia, other, Lip, Oral Cavity and Pharynx, Liver, Lung, Lymphoid Leukemia, Melanoma, skin, Multiple Myeloma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Other Hematopoietic, Unknown Sites M14-546 - Phase I Dose Escalation of ABBV-075
Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Soft Tissue, Phase I Safety Study of MGA271 in Combination With Ipilimumab in Refractory Cancer
Anus, Bladder, Breast - Female, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Phase I, Unknown Sites A Phase 1B Dose-Escalation Study of GDC-0919 With MPDL3280A in Patients with Advanced or Solid Tumor
Anus, Bladder, Brain and Nervous System, Breast - Female, Breast - Male, Cervix Uteri, Colon, Corpus Uteri, Esophagus, Eye and Orbit, Kaposi's sarcoma, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Mycosis Fungoides, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Phase I Exploring the safety, tolerability, effect on tumor environment and efficacy of INCB combinations
Anus, Bladder, Breast - Female, Breast - Male, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Phase I, Unknown Sites A Study of RO6958688 in Patients With Locally Advanced and/or Metastatic Solid Tumors
Anus, Bladder, Breast - Female, Breast - Male, Colon, Esophagus, Kidney, Larynx, Leukemia, other, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Multiple Myeloma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Other Hematopoietic, Phase I A Dose-Escalation Study of MOXR0916 & MPDL3280A in Locally Advanced or Metastatic Solid Tumors
Breast - Female, Colon, Hodgkin's Lymphoma, Lung, Non-Hodgkin's Lymphoma, Ovary, Pancreas NCI 7977
Kidney, Lung, Melanoma, skin, Phase I A phase 1/2 Dose escalation and expansion study of NKTR-214 in patients with adv. or met. tumors
Anus, Bladder, Bones and Joints, Brain and Nervous System, Breast - Female, Breast - Male, Cervix Uteri, Colon, Corpus Uteri, Esophagus, Eye and Orbit, Hodgkin's Lymphoma, Kaposi's sarcoma, Kidney, Larynx, Leukemia, not otherwise specified, Leukemia, other, Lip, Oral Cavity and Pharynx, Liver, Lung, Lymphoid Leukemia, Melanoma, skin, Multiple Myeloma, Mycosis Fungoides, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Other Hematopoietic Patient-Derived Models Tissue Procurement Protocol for NCI
Anus, Bladder, Breast - Female, Breast - Male, Colon, Esophagus, Hodgkin's Lymphoma, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Liver, Lung, Melanoma, skin, Non-Hodgkin's Lymphoma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Phase I, Unknown Sites Phase 1-2 Study of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
Cervix Uteri, Ovary, Phase I D3610C00001 - Phase I of AZD5363 under Adaptable Dosing Schedules in Solid Tumors
Bladder, Breast - Female, Colon, Lung, Ovary, Phase I PHASE IB STUDY WITH EXPANSION PHASE TO EVALUATE RO5509554 AND MPDL3280A
Bladder, Colon, Kidney, Lip, Oral Cavity and Pharynx, Lung, Melanoma, skin, Rectum, Phase I Phase 1 First-in-Human Study of AMG 228 in Selected Advanced Solid Tumors
Anus, Bladder, Breast - Female, Colon, Esophagus, Kidney, Larynx, Leukemia, other, Lip, Oral Cavity and Pharynx, Liver, Lung, Lymphoid Leukemia, Melanoma, skin, Multiple Myeloma, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Stomach, Thyroid, Other Hematopoietic, Phase I GO29653 - A Phase Ib study of the combination of
Lung, Melanoma, skin, Ovary, Soft Tissue, Phase I Phase 1b Study Evaluating the Safety, Tolerability and Immunogenicity of CMB305 in NYESO1 Patients
Melanoma, skin, Phase I Varlilumab and Nivolumab in advanced refractory solid tumors
Soft Tissue, Phase I Phase 1 Study of Mogamulizumab (KW-0761) in Combination with MEDI4736 & Mogamulizumab in Combinati
Bladder, Colon, Lip, Oral Cavity and Pharynx, Lung, Rectum, Phase I A Phase 1 Study of MEDI6383 (an OX40 Agonist) in Adult Subjects with Select Advanced Solid Tumors

Edit this profile

Contact Info

Joseph Paul Eder, MD
Patient Care Location
Yale Cancer CenterYale-New Haven Hospital
20 York Street, Ste North Pavilion 8

New Haven, CT 06510
View on map...
Mailing Address
PO Box 208028
New Haven, CT 06520-8028

Curriculum Vitae